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The developing diaphragm consists of various differentiating cell types, many of which are not well
characterized during organogenesis. One important but incompletely understood tissue, the diaphrag-
matic mesothelium, is distinctively present from early stages of development. Congenital Diaphragmatic
Hernia (CDH) occurs in humans when diaphragm tissue is lost during development, resulting in high
morbidity and mortality postnatally. We utilized a Wilms Tumor 1 (Wt1) mutant mouse model to in-
vestigate the involvement of the mesothelium in normal diaphragm signaling and development. Ad-
ditionally, we developed and characterized a Wt1CreERT2-driven β-catenin loss-of-function model of CDH
after ﬁnding that canonical Wnt signaling and β-catenin are reduced in Wt1 mutant mesothelium. Mice
with β-catenin loss or constitutive activation induced in the Wt1 lineage are only affected when ta-
moxifen injection occurs between E10.5 and E11.5, revealing a critical time-frame for Wt1/ β-catenin
activity. Conditional β-catenin loss phenocopies the Wt1 mutant diaphragm defect, while constitutive
activation of β-catenin on the Wt1 mutant background is sufﬁcient to close the diaphragm defect. Pro-
liferation and apoptosis are affected, but primarily these genetic manipulations appear to lead to a
change in normal diaphragm differentiation. Our data suggest a fundamental role for mesothelial sig-
naling in proper formation of the diaphragm.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The diaphragm is an essential, and often overlooked, re-
spiratory organ that functions in breathing, esophageal contrac-
tion, separation of the body cavities and regulation of ﬂuids in the
thoracic and abdominal cavities (Abu-Hijleh et al., 1995; Bordoni
and Zanier, 2013; Pickering and Jones, 2002). Congenital Dia-
phragmatic Hernia (CDH) is a relatively common birth defect oc-
curring in approximately 1 in 3000 live births, and as many as 1 in
2000 pregnancies, and is a major source of mortality and mor-
bidity (Greer, 2013; Harrison et al., 1994). CDH is a birth defect
affecting more than just the diaphragm, as more often a complex
spectrum of defects are present in the heart and lungs. This can be
due to primary genetic mechanisms, as well as secondary me-
chanical issues (Ackerman et al., 2005; Babiuk and Greer, 2002;
Chiu, 2014). The most common and most severe types of CDH
occur in the posterior and lateral regions, which have historically
been grouped as “Bochdalek” hernias (Ackerman et al., 2012;ical Research, University of
ood Ave, Box 611, Rochester,
u (K.G. Ackerman).Pober, 2007). In embryonic development, the pleuroperitoneal
folds (PPFs), present at E11.5–E12.5 in the mouse, are thought to
contribute to a substantial portion of the diaphragm mesenchyme
(Greer et al., 2000). It is believed that prior to this event, the
septum transversum forms the anterior region, or central tendon,
of the diaphragm (Yuan et al., 2003). The mature diaphragm is
made up of various tissue types including muscle, tendon, con-
nective tissue, nerve, blood vessels, lymphatics and mesothelium
(Ackerman and Greer, 2007; Zhang et al., 2014). Defects in several
of these diaphragmatic cell types have been investigated in genetic
mouse models of CDH, including connective tissue (Ackerman
et al., 2005; Jay et al., 2007; Merrell et al., 2015; You et al., 2005),
tendon (Coles and Ackerman, 2013; Domyan et al., 2013; Yuan
et al., 2003), and blood vessels (Zhang et al., 2014). Mesothelium
and non-muscle mesenchyme are present throughout diaphragm
development, but have yet to be fully characterized.
The mesothelium is a mesoderm-derived epithelial-like cell
layer important for lubrication of internal organs via secretion of
surfactant. Recently, a developmental role has been established for
mesothelial cells, as they have been shown to contribute to the
mesoderm of organs such as the heart, lungs, liver and gut (Asa-
hina et al., 2011; Que et al., 2008; Wilm et al., 2005; Zhou et al.,
2008). In early development, mesothelium is present after
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cells are able to differentiate into adipocytes, chondrocytes, and
osteoblasts; as well as ﬁbroblasts and smooth muscle cells in in
vitro models, which may reﬂect their contribution in embryonic
development (Batra and Antony, 2014). The cellular characteristics
of the mesothelium are uniquely associated with both epithelial
and mesenchymal morphology and expression. Due to this feature,
both cuboidal and squamous types of mesothelial cells exist,
where squamous are thought to be the most differentiated form
(Herrick and Mutsaers, 2004). Cuboidal mesothelial cells coating
highly mobile organs are biosynthetically active with primary cilia,
abundant Golgi, rough endoplasmic reticulum, microvilli, lamellar
bodies, basement membrane, cell–cell junctions, and extensive
cytoskeletal networks (Bird, 2004). These cellular characteristics
are important for tensile strength and ﬂexibility. In the pleural
cavity, mature mesothelial cells play a critical role in inﬂammatory
response, ﬂuid homeostasis, and maintenance of the elasticity
required for organs to expand during development (Charalampidis
et al., 2015). Mesothelial cells at different stages of maturation and
with unique gene expression can be found predominantly on the
thoracic surface of the developing diaphragm, while mesothelium
on the abdominal side develops at later stages after complete se-
paration of the diaphragm from the liver (Shinohara, 1997). Me-
sothelial Slit-Robo signaling may be critical to the development of
the central tendon of the diaphragm, as proper signaling is ne-
cessary to ensure that the anterior diaphragm correctly separates
from the liver and maintains its integrity (Domyan et al., 2013;
Yuan et al., 2003).
The genetic mechanisms that function in diaphragm develop-
ment are still largely unknown. Several genes have been im-
plicated in normal diaphragm development and are associated
with human CDH, but the extensive study of mouse genetic
models is often limited by embryonic lethality (Ackerman et al.,
2005; Beurskens et al., 2007; Jay et al., 2007; You et al., 2005). One
of these genes, Wilms Tumor 1 (Wt1), was determined to be ne-
cessary for diaphragm development in a mouse model of ur-
ogenital developmental defects (Kreidberg et al., 1993). Ad-
ditionally, limited studies of the Wt1 null embryonic diaphragm
identiﬁed defects in the posterolateral region, possibly originating
from lost PPF tissue early in diaphragm development (Clugston
et al., 2006). Wt1 is a zinc ﬁnger transcription factor/tumor sup-
pressor important for organogenesis, which is expressed in the
urogenital system as well as by the mesothelium lining the body
wall and covering the heart, lungs, diaphragm, and liver beginning
at E9.5 (Moore et al., 1998; Rackley et al., 1993). It has been es-
tablished that Wt1 is mutated in several complex human diseases
such as Denys-Drash, Meacham, and Frasier syndromes, at times
presenting with CDH (Antonius et al., 2008; Suri et al., 2007). Wt1
acts upstream of a variety of genes to regulate numerous processes
during development (Wagner et al., 2003). Previous ﬁndings in the
kidney have identiﬁed Wt1 downstream targets in diverse path-
ways, including MAP kinase signaling, axon guidance, and Wnt
signaling (Kim et al., 2009).
Canonical Wnt signaling is responsible for many cellular pro-
cesses such as cell proliferation, cell fate speciﬁcation, and differ-
entiation (Logan and Nusse, 2004). Genes associated with Wnt
signaling in the diaphragm have been shown to be preferentially
expressed during early organogenesis, and a few Wnt pathway
members have been indirectly associated with human CDH (Rus-
sell et al., 2012; Wat et al., 2011). A connection between Wt1 and
Wnt signaling has been previously elucidated in the heart, where
it has been suggested that Wt1 acts upstream of β-catenin to
regulate epithelial–mesenchymal transition (EMT) (Von Gise et al.,
2011). Wt1 binding sites have also been identiﬁed and validated in
several Wnt pathway members; including Lef1 in the kidney and
posterior taste ﬁeld of the tongue (Gao et al., 2014; Hartwig et al.,2010). Apart from a role for Wnt signaling in skeletal muscle
maturation during late embryogenesis, Wnt has not yet been im-
plicated in the process of diaphragm development (Mathew et al.,
2011).
In this study, we propose one mechanism of Wt1 function in
diaphragm development in which canonical Wnt signaling is
promoted by targeting β-catenin. We show data demonstrating
that Wnt signaling in diaphragm development is required during a
speciﬁc time in a distinct subset of non-muscle cells, which pri-
marily includes mesothelial cells. We have further elucidated the
function of Wt1 as well as developed a new conditional genetic
model using the inducible Wt1CreERT2 mouse, which survives until
birth. This model expands opportunities for the investigation of
developmental mechanisms in the diaphragm as previous models
such as the Wt1 null mutant only live until E13.5–E14.5 (Clugston
et al., 2006; Kreidberg et al., 1993). To our knowledge, we are the
ﬁrst to propose a role for mesothelial signaling in the development
of the posterior diaphragm.2. Materials and methods
2.1. Experimental mice and genotyping
All animal studies were approved by the University Committee
on Animal Resources at the University of Rochester Medical Center.
R26Rlacz (JAX: 003309) and BATgal reporter mice (JAX: 005317)
were purchased from the Jackson laboratory (Maretto et al., 2003;
Soriano, 1999). Axin2lacz (JAX: 009120), TOPgal (JAX: 004623),
Bcatfx (Ctnnb1tm2Kem; JAX: 004152), and Bcatex3fx (Ctnnb1tm1Mmt;
MGI:1858008) mice were provided by Wei Hsu (Department of
Biomedical Genetics, University of Rochester, Rochester, NY)
(Brault et al., 2001; DasGupta and Fuchs, 1999; Harada et al., 1999;
Lustig et al., 2002). These strains were genotyped as described by
the Jackson Laboratory.
Wt1GFPCre (JAX: 010911) andWt1CreERT2 (JAX: 010912) mice were
obtained from William T. Pu (Department of Cardiology, Children’s
Hospital Boston, Boston, NY) and maintained by our lab on the
outbred Swiss Webster (CFW) line (Zhou et al., 2008). Wt1GFPCre
mice were used to analyze Wt1 loss for all experiments other than
the rescue experiment, where it was necessary to use Wt1CreERT2.
Both strains of mice lack the ﬁrst coding exon of Wt1 and were
genotyped by Cre PCR (Cre313F- 5′-CCACGACCAAGTGACAGCA-
ATG-3′, Cre705R- 5′-TTCGGATCATCAGCTACACCAGAG-3′ Euroﬁns
Genomics, annealing temp 60°). To distinguish Wt1 heterozygous
embryos from homozygotes, TaqMan duplex allelic discrimination
analysis of yolk sac DNAwas carried out to detect Cre copy number
compared to control Beta-microglobulin exon sequence. BioRad iQ
Supermix buffer was used as well as primers and probes from
Biosearch Technologies, listed below. Assays were run at an an-
nealing temperature of 55°.
Cre F Primer 5′-CCGCAGGTGTAGAGAAGGC-3′
Cre R Primer 5′-AACAGGTAGTTATTCGGATCATCAG-3′
BMG F Primer 5′-TTGTCATGTTGGTTGAGAAGCAG-3′
BMG R Primer 5′-TATGAACTCAGGTGGTCAGGTTG-3′
BMG Probe CAL Fluor Red 610-5′-TGCTGAGCCATACCACTG-
CCATCTT-3′-BHQ-2
Cre Probe FAM-5′-ACACCAGAGACGGAAATCCATCGCT-3′-BHQ-1
Where it was necessary to detect GFP, Wt1GFPCre heterozygotes
were used as littermate controls because they were phenotypically
normal during embryonic development. Homozygous mice
(Wt1GFPCre/GFPCre) are denoted as Wt1 null or mutant given that the
Cre is a knock-in construct. In some experiments, Wt1GFPCre mice
were bred toWt1CreERT2 heterozygotes to maintain one copy of GFP
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entiate Wt1GFPCre fromWt1CreERT2 alleles with Wt1 and Cre primers
as follows: Wt1F-5′-AGAATCCGCAGGATCGCAGGAG-3′, Cre4002R-
5′-GCTTGCATGATCTCCGGTAT-3′, annealing temp 60°. Cre-negative
embryos were used as a wildtype control unless otherwise in-
dicated. Wt1CreERT2/þ;Bcatfx/þ (one allele LOF) embryos were de-
termined to be phenotypically normal, thus β-catenin homozygous
loss-of-function embryos were generated.
2.2. Embryo generation and histology
Embryos were harvested at E10.5–E15.5, where noon of the day
the mucous plug was observed was considered E0.5. For some
conditional β-catenin loss-of-function experiments, pups were
collected just after birth and dissected for phenotypic analysis.
Yolk sacs were removed for DNA extraction. To induce activation of
Wt1CreERT2, 2–2.5 mg of 10 mg/ml tamoxifen (MP Biomedical
#156738), dissolved in sesame oil at 37 °C, was injected in-
traperitoneally into pregnant females (Zhou and Pu, 2012). Mice
were injected once between E8.5 and E12.5. Embryos were ﬁxed
overnight at 4 °C in 4% paraformaldehyde in PBS for sectioning or
10% formalin for gross dissection. Parafﬁn sections were cut at
7 mm and stained with hematoxylin and eosin (H&E) using stan-
dard methods for histological analysis. For histological staining of
elastin ﬁbers, Hart's Stain was used and sections were counter-
stained with eosin or tartrazine. Unless otherwise noted, each
experiment was conducted in embryos from three separate litters
for a given age.
2.3. X-gal staining
To detect β-galactosidase expression in the Lacz reporter mice,
whole embryos at E10.5–E11.5 or partially dissected embryos at
E12.5–E14.5 were ﬁxed in a 0.2% gluteraldehyde, 5 mM EGTA,
2 mM MgCl2 solution overnight at 4 °C. Embryos were then per-
meabilized with a solution of 100 mM sodium phosphate buffer
pH 7.3, 0.02% NP40, 0.01–0.05% sodium deoxycholate, and 2 mM
MgCl2 for at least 30 min. Embryos were then incubated in a
staining solution of 5 mM potassium ferricyanide, 5 mM po-
tassium ferrocyanide, 50 mg X-gal (Lab Scientiﬁc), and permeabi-
lization buffer overnight at room temperature (Nagy et al., 2007).
Tissue was post-ﬁxed in 10% formalin, or 4% paraformaldehyde for
immunostaining. Parafﬁn sections (10 mm) were then counter-
stained with Nuclear Fast Red. For frozen sections, embryos at
E11.5–E13.5 were ﬁxed as described above, washed in 30% sucrose,
and embedded in OTC. Cryosections (10 mm) were post-ﬁxed with
0.2% gluteraldehyde prior to X-gal staining.
2.4. Immunostaining
Parafﬁn tissue sections were prepared for immunoﬂuorescence
or immunohistochemistry following standard methods. Antigen
retrieval was performed in a Food Steamer (Oster #5711) in 10 mM
sodium citrate pH 6.0, 0.05% Tween 20 or 10 mM Tris, 1 mM EDTA
pH 9.0, 0.05% Tween 20 buffer for 20 min (after preheating
20 min). For some antibodies, more extensive antigen retrieval in a
pressure cooker at 120 °C for 20 min was necessary. Primary an-
tibodies used were as follows: rabbit anti-Wilms Tumor 1 (1:500;
Abcam; ab89901), mouse anti-BrdU (1:300; BD Biosciences;
#347580), rabbit anti-Cleaved Caspase 3 (1:500; Cell Signaling;
#9661), mouse anti-Myosin (MF20) (1:100; DSHB; AB_2147781),
mouse anti-Active β-catenin (anti-ABC) (1:500; Millipore; 05-
665), chicken anti-GFP (1:300; Abcam; ab13970), goat anti-Podo-
calyxin (1:200; R&D Systems; AF1556), mouse anti-Collagen1a1
(1:250; Sigma; SAB1402151), rabbit anti-TCF4 (1:300; Cell Signal-
ing; C48H11), rabbit anti-PDGFRA (1:500; Cell Signaling; D1E1E),mouse anti-Twist1 (1:250; Santa Cruz; sc-81417), rabbit anti-Sox9
(1:1000; Millipore; AB5535), mouse anti-N-Cadherin (1:500; BD
Biosciences; 610920), mouse anti-P-Cadherin (1:10; Abcam;
ab75442), and mouse anti-E-Cadherin (1:500; BD Biosciences;
610182). A second Wt1 antibody (mouse anti-human) was needed
for co-labeling with antibodies raised in rabbit (1:20–1:100;
ThermoScientiﬁc; 6F-H2). Secondary antibodies for immuno-
ﬂuorescence were purchased from Life Technologies and were
applied at 1:200 dilution with Hoechst stain (1:1000; Thermo-
scientiﬁc). For IHC, biotinylated goat anti-rabbit or goat anti-
mouse (1:300; Vector; BA-1000 or BA-9200, respectively) were
used. Streptavidin-Peroxidase polymer (Sigma S2438) was applied
at 1:500 for one hour prior to application of DAB substrate (Abcam
ab64238). For IHC of Active β-catenin, the Vector M.O.M. im-
munodetection kit (BMK-2202) was used. To amplify IHC signal of
low background-producing antibodies such as Twist1 and TCF4,
the peroxidase Vector ImmPRESS Reagent (MP-7402 or MP-7401)
was used. The MF20 (Myosin) antibody developed by Fischman, D.
A. at Weill Cornell Medical College was obtained from the Devel-
opmental Studies Hybridoma Bank, created by the NICHD of the
NIH and maintained at The University of Iowa, Department of
Biology, Iowa City, IA 5224.
2.5. Cell proliferation and cell death analysis
Pregnant females were injected intraperitoneally with 20 mg/
ml bromo-deoxyuridine (BrdU) (Sigma B5002) at 50–100 mg per
one gram mouse weight one hour before embryo harvest for cell
proliferation experiments. Embryos were ﬁxed in 4% paraf-
ormaldehyde and processed in parafﬁn for immunoﬂuorescence of
tissue sections. Wt1GFPCre and Wt1CreERT2 mice were crossed to
generate Wt1 null and heterozygous embryos, maintaining one
copy of GFP in both genotypes. Wt1GFPCre/CreERT2 embryos were
compared to their respective Wt1GFPCre/þ littermates. Wt1CreERT2/þ;
Bcatfx/fx and Wt1CreERT2/þ; Bcatex3fx/þ embryos were harvested after
tamoxifen injection at E10.5 and compared to their respective
Wt1þ /þ littermates. Co-immunoﬂuorescence for Wt1 (or GFP) and
BrdU was performed on comparable sections in four different re-
gions (one per slide) of the left and right diaphragm at E12.5. The
number of Wt1/GFP, BrdU positive cells, and double positive cells
in the mesothelial layer (any cell lying adjacent to the pleural
cavity) of the posterior diaphragm was counted, along with total
number of mesothelial cells, in at least three sections in each re-
gion. Cell death analysis was carried out on different sections of
the same E12.5 embryos by immunoﬂuorescent staining of
Cleaved Caspase 3 on four slides per embryo. Cleaved Caspase
3-positive cells in the entire posterior diaphragm were counted
and compared to the total number of posterior cells.
These experiments were performed in at least three different
sets of littermates for each genotype. ImageJ software was utilized
for cell counting and merging ﬂuorescent images (Schneider et al.,
2012). Cell counts were recorded as a percent of total Hoechst-
positive cells. Mutant cell counts were normalized to the control
for visualization of the relative rate of cell proliferation/cell death.
Statistical signiﬁcance was determined using a two-tailed t-test
assuming unequal variance, where Po0.05 was considered sig-
niﬁcant and mutants were compared to their respective littermate
control (not one another). Data was plotted using Standard Error of
Mean. P values were reported as calculated by t-test, but sig-
niﬁcance was also validated by One-Way ANOVA.
2.6. Imaging and microscopy
Leica MZ 12-5 and Leica DM 5500B microscopes were used to
image samples. A Leica MC 170HD camera was used to capture
color images and a Leica DFC 365FX camera to capture ﬂuorescent
Fig. 1. Wt1 contribution shifts in developing diaphragm mesothelium and mesenchyme in a time-dependent manner. Immunohistochemistry (A, C, G, J) was performed on
tissue sections fromwildtype mice at E11.5 to E15.5 to detect Wt1 protein localization in the developing diaphragm. Fate mapping was performed using whole-mount (B, D–
F, H, K, L), or cryosectioned (I), X-gal stained Wt1CreERT2; R26Rlacz embryos harvested at E11.5 to E15.5 with recombination induced by tamoxifen injection at E8.5 (B, D, H),
E9.5 (E, I), or E10.5 (F, K, L). Wt1 protein and Wt1-derived cells were localized to mesothelium of the PPF (arrows) in transverse sections at E11.5 (A, B). Injecting at different
time points resulted in restricted patterns of lacz expression in sagittal sections at E12.5 (dotted lines) (D–F). Arrows indicate concentrated regions of Wt1 protein and Wt1
fate-mapped cells at E13.5 (G–I) and E15.5 (J–L). A whole X-gal stained diaphragm (K) at E15.5, injected at E10.5, is shown with a corresponding sagittal section (L). Low
magniﬁcation H & E stained sections of representative wildtype embryos at E11.5 (M) and E12.5 (N) have relevant tissues and orientation labeled which is maintained
throughout subsequent ﬁgures. Abbreviations: L, lung; Li, liver; PPF, pleuroperitoneal fold. The liver/diaphragm boundary is represented by a dotted line (C) where necessary.
Scale bars: A, B, J, and L, 100 mm; C–I, M and N, 200 mm; K, 1 mm.
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acquire images. Image editing and addition of scale bars was done
using ImageJ software.3. Results
3.1. Wt1 contributes to the diaphragm mesothelium and mesench-
yme in an age-dependent manner
Wt1 expression in organogenesis is typically restricted to either
the mesenchyme (kidney and gonad) or the mesothelium (visceral
organs and body cavity lining).Wt1 is expressed in the non-muscle
mesenchyme of the primordial diaphragm (pleuroperitoneal folds)
(Clugston and Greer, 2007), but speciﬁc localization of Wt1 ex-
pression during maturation of the embryonic diaphragm is un-
known. For this reason, we examined Wt1 expression in wildtype
mouse embryos during the entire process of diaphragm develop-
ment (E11.5–E15.5). Unlike other Wt1-expressing organs, we de-
termined that the diaphragm actively expresses Wt1 in both me-
sothelium and a subset of mesenchymal cells throughout dia-
phragm organogenesis, though Wt1 protein remains heavily lo-
calized to the mesothelium during this time (Fig. 1A, C, G, and J). To
further characterize Wt1-positive mesenchymal cells, we utilized
antibodies targeting the non-muscle mesenchyme and the muscle
ﬁbers. To identify a new non-muscle mesenchymal marker, ex-
pression analysis was conducted to determine the localization of
the transcription factor Twist-related protein 1 (Twist1) in the
diaphragm. Twist1, a mesoderm-determining factor important for
speciﬁcation and differentiation during mouse development, is
expressed in many different tissues, including Wt1-derived cells in
the heart (Qin et al., 2012; Zhou et al., 2011). We found that the
Wt1-positive diaphragmatic mesenchyme largely corresponds to
Twist1-positive undifferentiated mesenchyme (70% overlap at
E13.5), and these cells do not overlap with skeletal muscle markers
(Supplementary Fig. 1A–D). The presence of Wt1 in speciﬁc dia-
phragmatic cell types during a critical period of development
suggests that it plays a distinct role in the formation of a functional
diaphragm.
The temporal contribution of Wt1-expressing cells to the dia-
phragm was examined to investigate Wt1 function and to char-
acterize conditional mouse tools for further study of diaphragm
development. Tamoxifen inducible Wt1CreERT2 mice were de-
termined to be most effective for this study, as Wt1GFPCre mice are
non-inducible and wide recombination of R26Rlacz (due to ubi-
quitous early expression) precluded speciﬁc labeling of cells in the
diaphragm (unpublished results). Wt1CreERT2 mice have been suc-
cessfully utilized to lineage trace mesothelial cells in other tissues
such as the epicardium of the heart (Zhou et al., 2008). Although
this mouse model is ideal for investigating potential epithelial–
mesenchymal transition (EMT) mechanisms in other organs, the
presence of Wt1 expression in both mesothelial and mesenchymal
diaphragmatic cells limits analysis in this tissue. Despite this
limitation, the Wt1CreERT2 mouse line is a very effective tool for
mapping Wt1-expressing cells during development in a time-de-
pendent manner. Wt1CreERT2; R26Rlacz embryos, injected with ta-
moxifen at E8.5 to induce reporter activity, were analyzed at
E11.5–E13.5 (Fig. 1B, D and H). Analysis of Wt1 lineage labeling
induced at this time rarely showed staining as robust as age-
matched Wt1 antibody staining. To rule out incomplete penetra-
tion of X-gal staining buffer, the speciﬁcity of the fate map staining
pattern was veriﬁed by examining X-gal stained cryosections of
PPF tissue at E11.5 (Supplementary Fig. 1I). We also established
that whole mount X-gal staining was consistent with previously
reported labeling of the Wt1 lineage in the developing heart and
lungs (Supplementary Fig. 1F) (Que et al., 2008; Zhou et al., 2008).We then induced R26Rlacz reporter expression in the developing
diaphragm at ages E9.5 and E10.5 to analyze the pattern of Wt1
contribution at E12.5 (Fig. 1D–F) and E13.5 (Fig. 1H and I). When
Wt1 lineage labeling occurs at E10.5 (Fig. 1F), rather than E8.5-
E9.5, there is a noticeable shift in the lacz staining pattern, re-
vealing a heavier contribution to the posterior diaphragm evident
as early as one day after Cre activation (Supplementary Fig. 1J and
K). These ﬁndings were validated by Wt1 antibody staining of
X-gal stained sections at E12.5, which showed a signiﬁcantly in-
creased overlap of Wt1 contribution and protein in the posterior
diaphragm of embryos injected at E10.5 (Supplementary Fig. 1G
and H). The age-speciﬁc pattern of Wt1 contribution seen after
induction at E10.5 coincides with a time of signiﬁcant tissue
growth and migration, as observed by others through morpholo-
gical examination of the developing primordial diaphragm, im-
plicatingWt1 in functions necessary for this process (Merrell et al.,
2015). By E15.5, Wt1 protein localization in the mature diaphragm
becomes more restricted to the mesothelium (Fig. 1J). In contrast,
Wt1 fate-mapped cells were detected in the entire diaphragmatic
mesothelial surface and were highly concentrated in the body wall
connection of the posterior diaphragm (Fig. 1K and L). Interest-
ingly, this site is also a region that is vulnerable to diaphragmatic
defects. These ﬁndings suggest that there are dynamic changes in
the pattern of Wt1 contribution and expression in the mesothe-
lium and mesenchyme throughout diaphragm development that
have not previously been appreciated. Further investigation is still
needed to elucidate the mechanisms in which Wt1 functions in
diaphragm development.
3.2. Normal β-catenin expression in the diaphragm mesothelium is
regulated by Wt1
Wt1 target genes involved in diaphragm function have not yet
been identiﬁed. Wnt is one of several signaling pathways with
preferential gene expression during early diaphragm development
that also falls downstream of Wt1 signaling in other organs (Kim
et al., 2009; Russell et al., 2012). By co-immunoﬂuorescence, we
found that β-catenin is present in a subset of Wt1-expressing
mesothelial cells at both early and later stages of normal dia-
phragm development, in addition to expected expression in the
muscle ﬁbers (Fig. 2A and B) (Kuroda et al., 2013). To determine if
β-catenin is affected by the loss of Wt1, homozygous null embryos
were generated using the Wt1GFPCre mouse line and analyzed by
antibody staining. Notably, mesothelial protein levels of both ac-
tive (Fig. 2C and D) and total (Supplementary Fig. 2E and F) β-
catenin were signiﬁcantly reduced in Wt1 mutant diaphragms,
with no alteration of expression in muscle ﬁbers. Since β-catenin
has additional roles independent of Wnt signaling, further studies
were needed to verify that canonical Wnt signaling is altered in
the Wt1 mutant diaphragm.
For subsequent analysis of canonical Wnt signaling in the dia-
phragm, we utilized the Axin2lacz reporter mouse, a knock-in
construct reﬂecting the endogenous expression of downstream
target Axin2 upon activation of the Wnt pathway. Whole mount
analysis of this reporter in the wildtype diaphragm at E12.5 re-
vealed more concentrated staining in the late PPF (the future
posterior diaphragm) compared to the expanding anterior dia-
phragm; where individual, stained mesothelial cells are visible
above the unstained liver (Fig. 2E). These ﬁndings suggest that
Axin2lacz faithfully recapitulates mesothelial β-catenin localization
visualized in tissue sections of the developing diaphragm. In X-gal
stained embryos generated from Axin2lacz;Wt1GFPCre heterozygous
matings, mesothelial staining was drastically reduced in the Wt1
null posterior diaphragm at E11.5 (Fig. 2F–I), similar to the speciﬁc
reduction of β-catenin protein that was observed. Since Wnt re-
porter mice have never been characterized in the diaphragm, we
Fig. 2. Loss of Wt1 results in reduced β-catenin expression in posterior diaphragm mesothelium. Wt1/Active β-catenin co-immunoﬂuorescence was performed on sagittal
sections of wildtype embryos at E12.5 (A) and E13.5 (B). Wt1 nuclear protein corresponds to regions of Active β-catenin staining in the mesothelial cell cytoplasm (arrows).
Insets are cropped images of regions with yellow arrows. Active β-catenin immunohistochemistry (C, D) of E13.5Wt1GFPCre wildtype and mutant (Wt1GFPCre/GFPCre) diaphragms
labels regions of mesothelium (dotted line), indicated by arrows, as well as diaphragm muscle (asterisks) and lung epithelium (arrowheads). E12.5 whole mount X-gal
stained Axin2lacz wildtype embryonic diaphragm (E) has been outlined in white, with blue dotted lines marking late PPF, dorsal and ventral sides are indicated. Axin2lacz;
Wt1GFPCre embryos were harvested at E11.5 (F–I) and sectioned in transverse (F, G) and sagittal (H, I) orientation following whole mount X-gal staining. Insets are high
magniﬁcation of region marked by asterisk. Abbreviations: ABC, Active β-catenin; L, lung; Li, liver; PPF, pleuroperitoneal fold. Scale bars: A, B, H and I, 100 mm; C and D,
50 mm; F and G, 200 mm; E, 0.5 mm.
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mice carry multiple TCF/LEF binding sites (targeted by active Wnt)
artiﬁcially driven by ubiquitous promoters. We determined that
these reporters did not reﬂect both mesothelial and muscular
antibody staining of β-catenin, making the resulting X-gal staining
experiments in the Wt1 mutant diaphragm inconclusive (Supple-
mentary Fig. 2A–D). All three types of Wnt reporter mice haveshown variability depending on the tissue context, for instance in
the lung, where direct comparison has been carried out (Al Alam
et al., 2011). Since β-catenin expression has not been previously
characterized in the developing diaphragm, additional cell types
were evaluated to determine the entire localization. Connective
tissue cells that express Transcription factor 4 (TCF4) (Mathew
et al., 2011), a gene whose protein product forms a complex with
N.D. Paris et al. / Developmental Biology 407 (2015) 40–5646β-catenin during Wnt signaling in other tissues (Van de Wetering
et al., 2002), were a potential source of β-catenin expression in the
diaphragm. Given this association, we assayed TCF4/Active β-ca-
tenin overlap in the diaphragm by co-immunoﬂuorescence. Very
few TCF4-positive mesothelial cells are double positive for Active
β-catenin, therefore these cells do not account for the activation of
Wnt signaling seen throughout the diaphragm mesothelium in
Axin2lacz embryos (Supplementary Fig. 2G and H). TCF4 also does
not substantially overlap with markers of Wt1-positive non-
muscle mesenchyme in the posterior diaphragm such as Twist1,
indicating that TCF4-positive cells would not be expected to be
directly affected in Wt1 mouse models (Supplementary Fig. 1E).
Thus far, non-muscle β-catenin appears to be exclusively asso-
ciated with and regulated by Wt1 in the diaphragm mesothelium.
We next wanted to test whether β-catenin, in addition to Wt1,Fig. 3. Wt1-conditional loss of β-catenin leads to development of bilateral CDH similar t
and dissected to observe gross morphology compared to age-matched controls. H&E stain
with lung herniation circled.Wt1CreERT2; Bcatfx embryos, with Cre recombination induced
view diaphragm (C, D) and cardiopulmonary (E, F) morphology. The heart (outlined in re
in white) are present. Bilateral posterior diaphragm defects (asterisks) and the myotend
labeled in mutant diaphragms (B, D). H&E stainedWt1CreERT2;Bcatfx sagittal sections at E16
and heart compression (arrow), also shown in high magniﬁcation of lung sections at P0 (K
sections (M, N) conﬁrmed substantial loss of Active β-catenin in mutant mesothelium in
(arrows, M) are present in the wildtype, whereas in the mutant, Wt1-positive cells no lo
Insets are cropped images of regions labeled by yellow arrows. Asterisk denotes reten
mature diaphragms are pictured with the dorsal side at the bottom (A–D). Abbreviationplays a role in diaphragm signaling necessary for proper
development.
3.3. β-catenin in Wt1-expressing cells is necessary for proper dia-
phragm development
To determine if the loss of β-catenin is functionally signiﬁcant, a
conditional loss-of-function model using the inducible Wt1CreERT2
line was developed. First, comprehensive phenotypic analysis of
Wt1 null mature diaphragms was performed in order to have
detailed records for comparison when examining β-catenin deﬁ-
cient diaphragms. From 14 litters of Wt1GFPCre heterozygous mat-
ings harvested at E15.5, 38 of 124 (30.6%) total embryos screened
were genotyped as Wt1GFPCre homozygous (null) mutants, and 21%
of embryos had apparent intrauterine demise. All intact mutantso Wt1-null embryos. Wt1GFPCre homozygous mutants were collected at E15.5 (A, B)
edWt1GFPCre sagittal sections at E14.5 (G, H) have theWt1mutant diaphragm defect
at E10.5 by tamoxifen injection, were dissected at P0 with age-matched controls to
d) and lungs are displaced, though the correct number of lobes of the lung (outlined
onous junction at the central tendon (arrows), defective only in the Wt1 null, are
.5 (I, J) show liver herniation through the posterior defect (box) and associated lung
, L). Wt1/Active β-catenin co-immunoﬂuorescence of E13.5Wt1CreERT2;Bcatfx sagittal
the posterior diaphragm (arrowheads, N). Regions of Wt1/Active β-catenin overlap
nger overlap with few remaining Active β-catenin-positive cells (yellow arrow, N).
tion of positive Active β-catenin staining in mutant lung mesothelium (N). Whole
s: L, lung; Li, liver. Scale bars: A–F, I and J, 1 mm; G and H, 200 mm; K–N, 100 mm.
Fig. 4. Induction of constitutively active β-catenin in theWt1 lineage results in mesenchymal overgrowth sufﬁcient to closeWt1 null diaphragm defects. H&E stained sagittal
sections of Wt1CreERT2;Bcatex3fx embryos, injected with tamoxifen at E10.5 and harvested at E13.5 (A–D), illustrate phenotypes of single and double mutants compared to
wildtype. Yellow arrows indicate where nodules have formed in the gain-of-function diaphragm (B) and the affected region of the posterior diaphragm in theWt1 single and
double mutants is circled (C, D). Wt1CreERT2;Bcatex3fx;Axin2lacz embryos at E11.5 were whole-mount X-gal stained and sectioned sagittally (E, F). The positively stained
posterior diaphragm mesothelium is demarcated by dotted lines. Co-immunoﬂuorescence of Total β-catenin and Cleaved Caspase 3 was carried out on Wt1CreERT2;Bcatex3fx
E12.5 parafﬁn sections (G–J). Constitutively active β-catenin is shown in nodules (circle, H) and adjacent to Wt1 null diaphragm defects (asterisks, J). Presence of only
membranous total β-catenin is indicated in singleWt1 null (arrowhead, I). Co-immunoﬂuorescence was carried out at E13.5 of Wt1/Active β-catenin in diaphragm nodules in
β-catenin gain-of-function (K) and Collagen1a1/Podocalyxin (PCLP1) in Wt1CreERT2;Bcatex3fx double mutant (L) posterior diaphragms. Dotted line outlines the nuclei-dense
growth and arrowheads indicate loss of phosphorylation site-speciﬁc antibody staining where β-catenin exon 3 has been excised (K). Arrows indicate mesothelial fusion (L),
where diaphragm tissue has grown together after the initialWt1 defect was already formed. Arrowhead labels a region of wildtype localization of Col1a1. Abbreviations: HV,
Heart Ventricle; L, lung; Li, liver. Scale bars: A–D, 200 mm; E–J, and L, 100 mm; K, 50 mm.
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matic hernia (Fig. 3A and B) with some variation in severity. By
histological analysis of Wt1 null sagittal sections, posterior dia-
phragmatic hernia with lung herniation into the abdominal cavity
could be easily observed at E14.5 (Fig. 3G and H). We also noted
that central tendon patterning was disrupted, similar to a mouse
model we previously reported (Fig. 3B) (Coles and Ackerman,2013). We expected that if β-catenin is important in Wt1-expres-
sing cells, then a similar phenotype would be observed when it is
lost from cells in the Wt1 lineage.
Wt1-induced β-catenin loss-of-function (Wt1CreERT2/þ;Bcatfx/fx)
embryos harvested from dams injected at E10.5 died postnatally,
in contrast to the Wt1 null embryonic lethality that occurs at
E13.5–E15.5. Analysis of embryos collected at Postnatal Day 0 (P0)
N.D. Paris et al. / Developmental Biology 407 (2015) 40–5648revealed complete loss of the posterior diaphragm in all β-catenin
mutants examined (Fig. 3C and D), which is the same region af-
fected in the Wt1 mutant. The central tendon patterning appeared
unaffected in these mice, in contrast to Wt1 null mice. By eva-
luation of gross morphology, there was obvious bilateral pul-
monary hypoplasia and displacement of the heart associated with
liver herniation into the thoracic cavity, similar to phenotypes
associated with CDH in humans (Fig. 3E, F and I–L). As expected,
these pups were born gasping and cyanotic and were unable to
expand their lungs properly. The distal pulmonary air spaces are
collapsed when viewed by histology (Fig. 3K and L). Similar ﬁnd-
ings have been reported in other CDH mouse models, for instance
in Robo1;2 mutants where mispositioning of the stomach in the
thoracic cavity is observed (Domyan et al., 2013). The Wt1 mutant
also has complex lung defects, including rounded, abnormally
fused lung lobes, which have been previously characterized (Cano
et al., 2013). With Wt1-speciﬁc β-catenin loss, a normal number of
malformed, but appropriately separated, lung lobes were ob-
served. Further characterization of the Wt1CreERT2;Bcatfx embryos
was needed to verify tissue-speciﬁc β-catenin loss and to de-
termine if the effect seen was age dependent.
As we anticipated, Wt1CreERT2;Bcatfx diaphragm mesothelium
experienced a nearly complete loss of β-catenin not observed in
the muscle cells (Fig. 3M and N). Infrequent β-catenin-positive
cells that remained were Wt1-negative, consistent with a lack of
recombination in a small subset of mesothelial cells due to the
expression pattern of Wt1. The mesothelium retained normal le-
vels of Wt1 protein, however. This persistence of Wt1 expression
after β-catenin loss places β-catenin downstream of Wt1. Ad-
ditionally, we did not detect loss of β-catenin from the lung me-
sothelium, possibly a result of the speciﬁc timing of recombina-
tion. β-catenin deletion at E10.5 was crucial in order to observe a
diaphragmatic hernia phenotype. Tamoxifen injections occurring
before E10.5 (Supplementary Fig. 3) or after E11.5 (unpublished
data) were unable to induce a diaphragmatic phenotype. Active β-
catenin could still be detected by immunoﬂuorescence in some
diaphragm mesothelial cells of Wt1CreERT2/þ;Bcatfx/fx embryos in-
duced prior to E10.5 as well. These experiments have identiﬁed a
requirement for β-catenin in the diaphragm mesothelium during a
speciﬁc time in development. Gain-of-function experiments would
determine if β-catenin is sufﬁcient to drive processes in the de-
veloping diaphragm as well as further characterize the relation-
ship between Wt1 and β-catenin.
3.4. Wt1-driven constitutive activation of β-catenin is sufﬁcient to
close Wt1 null diaphragm defects
Excision of exon 3 of β-catenin via Cre-lox mouse tools renders
the protein incapable of being degraded normally in the cyto-
plasm, allowing excessive signaling of the Wnt pathway to take
place (Harada et al., 1999). Manipulation of β-catenin to drive ex-
pression of this stabilized form in other systems has resulted in
expansion of progenitor cells with inhibition of tissue differ-
entiation in a variety of contexts, including the diaphragm muscle
(Liu et al., 2012; Mirando et al., 2010). Upregulation of Wnt sig-
naling is also associated with human diseases involving abnormal
proliferation and differentiation such as pulmonary ﬁbrosis and
cancer (Moon et al., 2004). We hypothesized that β-catenin sta-
bilization in the diaphragm could promote similar processes in-
volving tissue expansion to prevent or reverse the formation of a
diaphragm defect in Wt1 null embryos. The inducible Wt1CreERT2
mice were crossed to the β-catenin exon 3-ﬂoxed (Bcatex3fx) mouse
line and double heterozygotes were mated to generate litters of
both wildtype and Wt1 null embryos with β-catenin activation.
When β-catenin was constitutively activated in the Wt1 lineage by
tamoxifen injection at E10.5 (Fig. 4A–D), we did, in fact, observeexcessive tissue growth with the formation of mesothelial-asso-
ciated nodules in diaphragms with wildtype Wt1 expression.
Furthermore, constitutively active β-catenin on the Wt1 null
background in these litters was able to ﬁll the diaphragm defect
with unorganized mesenchymal tissue (based on histological ap-
pearance) by E13.5. The embryonic lethality observed in the Wt1
mutant mice was not affected by activation of β-catenin, suggest-
ing that diaphragmatic Wt1/Wnt signaling is distinct from that of
the heart. Notably, in Wt1CreERT2; Bcatex3fx litters collected one day
prior to complete closure of the diaphragm defect (E12.5), the
process of mesenchymal expansion in double mutant diaphragms
was occurring, but the defect had not yet fully closed (Fig. 4J).
Similar to Wt1-induced loss-of-function, E10.5 was the optimal
time for induction of recombination that resulted in a phenotype.
There was no effect on the diaphragm with injection at E8.5,
though injection at E9.5 did result in a mild phenotype (formation
of small nodules)(Supplementary Fig. 3). When injected later, at
E11.5, β-catenin stabilization did drive some mesenchymal over-
growth, howeverWt1 null diaphragms were still left with an open
defect. It was important to further characterize the changes in
gene expression resulting fromWt1-speciﬁc β-catenin stabilization
in order to identify the mechanisms contributing to the observed
phenotype.
To conﬁrm activation of β-catenin, Wt1CreERT2;Bcatex3fx embryos
were assayed with the Axin2lacz reporter (Fig. 4E and F), revealing a
substantial upregulation of canonical Wnt signaling in diaphragm
mesothelium at E11.5. Immunoﬂuorescence revealed massive ac-
cumulation of total β-catenin protein (Fig. 4G–J) in regions of the
mesothelium and mesenchyme of the posterior diaphragm at
E12.5. The active β-catenin antibody, which targets depho-
sphorylated Ser37/Thr41 residues in exon 3, no longer labels most
mesothelial cells adjacent to nodules (Fig. 4K), given that the
stabilized β-catenin has had exon 3 removed. We were also able to
visualize the two mesothelial surfaces of the Wt1 null diaphragm
defect merging at E13.5 (Fig. 4L) following stabilization of β-ca-
tenin. This was observed by co-immunoﬂuorescence of mesothe-
lial-expressed Podocalyxin (PCLP1) (Onitsuka et al., 2010) and
Collagen1a1 (Col1a1), a component of the basement membrane of
mesothelial cells (Rennard et al., 1984). Collagen1a1 also displayed
expanded localization adjacent to the fusing mesothelium, possi-
bly indicative of enhanced activity of these cells, since normal
expression is restricted to the basal lamina. Interestingly, both β-
catenin conditional gain-of-function and loss-of-function embryos
are affected on the right, but not the left, side of the diaphragm if
injected too late in the day on E10.5 (E10.75) (unpublished re-
sults). This reﬂects previous work suggesting that the diaphragm
develops asymmetrically, since left-sided defects occur earlier
than right-sided ones in the nitrofen rat model of CDH (Allan and
Greer, 1997; Mayer et al., 2011). Our work identiﬁes an important
time window for β-catenin function around E10.5 in mouse em-
bryonic diaphragm development. Since we observed loss and gain
of tissue with β-catenin deletion and stabilization, respectively, we
subsequently wondered how cellular processes may be altered in
these models to drive their particular phenotypes.
3.5. Cell proliferation and apoptosis are regulated by Wt1 and β-
catenin signaling in the posterior diaphragm
Mouse models of CDH have been proposed to develop dia-
phragm defects through a variety of different defective cellular
mechanisms, supporting the idea that there may be several pos-
sible ways for a speciﬁc type of diaphragm defect to arise. For
example, the diaphragms of Gata4 heterozygous mice underwent
increased apoptosis, but had normal cell proliferation (Jay et al.,
2007), whereas nitrofen-exposed embryos were shown to have
decreased cell proliferation with no change in cell death (Clugston
Fig. 5. Wt1 and β-catenin regulate cell proliferation and cell death in the posterior diaphragm. Littermate pairs of E12.5 Wt1 null (Wt1GFPCre/GFPCre), β-catenin loss-of-function
(Wt1CreERT2/þ;Bcatfx/fx), and β-catenin gain-of-function (Wt1CreERT2/þ;Bcatex3fx/ex3fx), embryonic sections were co-stained for Wt1 (or GFP) and BrdU to assay cell proliferation
(A). Means of the relative percent of total single positive cells and double positive cells in the posterior diaphragm mesothelium were plotted with standard error of mean.
Representative sections (B, C) are shown where dotted lines indicate the mesothelium. E12.5 Wt1 null, β-catenin loss-of-function, and β-catenin gain-of-function embryonic
sections were also stained for Cleaved Caspase 3 to analyze cell death in the posterior diaphragm (D). Means of the relative percent of total Cleaved Caspase 3 positive cells
were plotted with standard error of mean. Representative sections (E, F) have dotted lines indicating the domain of the posterior diaphragm in which cells were counted.
N¼3 for both experiments. All values were compared to normalized littermate Cre-negative wildtype control (for β-catenin mice) or Wt1GFPCre heterozygous control
(nPo0.05, nnPo0.01, t-test). Scale bar: B–F, 100 mm.
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BrdU incorporation) and cell death (by Cleaved Caspase 3 staining)
in all three mouse models discussed above. Pregnant females were
injected intraperitoneally with bromo-deoxyuridine (BrdU) one
hour prior to harvesting embryos at E12.5, to remain consistent
with the work done in the nitrofen model as well as our own work
(Coles and Ackerman, 2013). E12.5 was the ideal age to assay, since
tamoxifen kinetics may prevent full recombination until up to a
day following injection (at E10.5) in the conditional models (Na-
kamura et al., 2006) and by E13.5, diaphragm defects have already
formed. In sagittal sections, diaphragmmesothelial cells labeled by
co-immunoﬂuorescence for Wt1 (or surrogate marker GFP in Wt1
null tissue), BrdU, or both, were counted and recorded as a per-
centage of all Hoechst-positive mesothelial cells in the posterior
diaphragm (Fig. 5A–C), given that this is the region where the
defects occur. The mesothelium was speciﬁcally assayed as this is
the location of Wt1 and β-catenin overlap and therefore this cell
type is possibly the source of these diaphragm defects. Interest-
ingly, we found that in all three models (Wt1 null, Bcat LOF, and
Bcat GOF), there was a signiﬁcant decrease (20–30%) in mesothe-
lial Wt1 (or GFP)-positive cells relative to the normalized control.
The number of cells that had incorporated BrdU had decreasedsigniﬁcantly (20%) in β-catenin loss-of-function diaphragm me-
sothelium, but had increased signiﬁcantly (60%) in the gain-of-
function model. Similar signiﬁcant changes were seen in the per-
centage of Wt1/BrdU double positive cells. No signiﬁcant change
was seen in the subset of cells that had incorporated BrdU, but
were Wt1-negative. An exception was the gain-of-function me-
sothelium which experienced a signiﬁcant increase in this cell
population similar to what was seen for all BrdU-positive and
double labeled cells. Representative Wt1/BrdU immunostained
sections of β-catenin loss-of-function (Fig. 5B and C),Wt1 null, and
β-catenin gain-of-function (Supplementary Fig. 4) embryos reﬂect
these ﬁndings. No signiﬁcant changes could be detected in total
cell number in the posterior mesothelium (Supplementary Fig. 4J),
which suggests loss of Wt1 (or GFP) expression rather than com-
plete loss of a subset of Wt1-positive cells. Cells in the entire
posterior diaphragm were also counted (Supplementary Fig. 4I) in
case there were additional defects in proliferation from non-cell-
autonomous signaling or mesenchymal Wt1 expression, but no
signiﬁcant differences could be detected. This result could also be
due to the fact that Wt1 and BrdU-positive cells only make up
about 20% of the posterior diaphragm, and the larger number of
single Hoechst-positive cells could dilute any real differences that
N.D. Paris et al. / Developmental Biology 407 (2015) 40–5650may be occurring. Since the BrdU incorporation in only a portion
of Wt1 (or GFP)-expressing cells was affected by Wt1 loss or β-
catenin manipulation, additional cellular processes could also be
affected.
Wt1 null, β-catenin loss-of-function, and β-catenin gain-of-
function embryonic sections were assayed for cell death by im-
munoﬂuorescence of Cleaved Caspase 3 at E12.5 (Fig. 5D–F). Cells
from the entire posterior diaphragm were counted in this case,Fig. 6. Activation of β-catenin in Wt1-expressing cells ampliﬁes a population of undiffe
reporter (A) were analyzed at E13.5 by sectioning following whole mount X-gal stainin
logical staining of elastin ﬁbers, which are apparent by regions of black/dark purple stain
and dotted lines (C) indicate an intact sub-mesothelial layer beneath the nodule, where p
basement membrane (D) at E13.5 is absent in regions of the nodule mesothelium (arrows
were detected through co-immunoﬂuorescence with mesothelial proteins Wt1 (E) and P-
diaphragm nodules were immunostained to detect connective tissue marker TCF4 (H) and
Cleaved Caspase 3 (I). At E13.5, mesothelial proteins N-Cadherin (J), P-Cadherin (K), and
positive regions of nodule mesothelium are indicated by arrows (J, K, L). Regions of know
are outlined with circles where necessary. Scale bars: A, B, D, E, G, and J–L, 100 mm; C,however, due to the localization and low number of caspase-po-
sitive cells. We saw a signiﬁcant change in all three models, where
Wt1 and β-catenin loss led to an approximately three-fold increase
in cells undergoing apoptosis. Stabilization of β-catenin had the
reverse effect, decreasing cell death by over 50%, which normally
occurs at very low levels in the diaphragm (Clugston et al., 2010).
In representative Cleaved Caspase 3 immunostained sections of β-
catenin loss-of-function (Fig. 5E and F), Wt1 null, and β-cateninrentiated mesenchymal cells. Wt1CreERT2;Bcatex3fx embryos containing the R26Rlacz
g. Nodules in Wt1CreERT2;Bcatex3fx diaphragms were further characterized by histo-
ing (arrowheads) of the mesothelial cell periphery at E13.5 (B) and E12.5 (C). Arrows
ink eosin-stained collagen ﬁbers could not be inﬁltrated. Collagen1a1 staining of the
). At E13.5 (E) and E12.5 (F, G), early mesenchymal markers Twist1, Sox9, and Pdgfra
Cadherin (F), as well as muscle marker MF20 (Myosin) (G).Wt1CreERT2;Bcatex3fx E13.5
Twist1 (inset, H) in serial sections of the same embryo, as well as cell death marker
E-Cadherin (L) were detected by co-immunoﬂuorescence with Wt1. Corresponding
n positivity in the lung are labeled with asterisks (J′, L′) or an arrow (K′). All nodules
F, and I, 50 mm; H, 200 mm.
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cessive Caspase 3 staining is generally detected in the region of the
posterior diaphragm closest to the connection to the body wall,
where diaphragm defects later form. Further immunoﬂuorescent
analysis of Caspase 3 localization was carried out in β-catenin loss-
of-function diaphragms with a different Wt1 antibody raised in
mouse (Supplementary Fig. 4K). Though cell death was present in
scattered mesenchymal cells, a subset of the Caspase 3-positive
cells near the body wall connection appeared to associate with
Wt1-positive cells, but were not double positive. We also observed
infrequent Caspase 3 staining in the mesothelium of the posterior
diaphragm, but overall, mesenchymal staining was much more
prevalent. These data suggest that Wt1 and β-catenin in the dia-
phragm mesothelium regulate cell proliferation by cell-autono-
mous signaling and apoptosis by non-cell-autonomous signaling.
With both of these cellular processes affected, it seemed that
normal differentiation of the diaphragm may also be affected by
perturbation of Wt1 or β-catenin.
3.6. Stabilization of β-catenin in the Wt1 lineage of the diaphragm
drives the accumulation of undifferentiated non-muscle mesenchyme
Since it is difﬁcult to identify a defective mechanism in the lost
diaphragm tissue of the Wt1 null and β-catenin loss-of-function
models, we believed that it would be beneﬁcial to use the β-ca-
tenin gain-of-function model to identify genes or processes that
are affected in this system in order enhance our understanding of
CDH models. Since Wt1 has previously been implicated in the
process of EMT in other tissues, we hypothesized that enhanced
transition of the mesothelial cells into mesenchymal cells due to
constitutively active β-catenin could be responsible for diaphrag-
matic nodule formation. Wt1CreERT2;Bcatex3fx mice were crossed to
the R26Rlacz reporter (Fig. 6A) and induced at E10.5 to label Wt1-
derived cells in the diaphragm nodules. The resulting fate map
showed that at least 80% of cells in the nodules were lacz positive.
These ﬁndings indicated that either the Wt1-expressing non-
muscle mesenchyme was being ampliﬁed or that new mesench-
ymal cells were being derived from Wt1-expressing mesothelium,
since only mesothelial Wt1 protein is detected in association with
the nodules (Fig. 4K).
We then assessed the integrity of the basement membrane of
mesothelial cells adjacent to nodules, since loss of these extra-
cellular matrix (ECM) components can be a hallmark of EMT, at
least in epithelial cells (Zeisberg and Neilson, 2009). Collagen
types I, III, and IV, laminin, ﬁbronectin, and elastin are just a few
proteins of the ECM associated with mesothelial cells in culture
(Rennard et al., 1984). Elastin ﬁbers lying beneath the mesothelial
cells were visualized histologically by Hart’s stain (Fig. 6B and C).
The darkly stained ﬁbers appeared to be continuous around the
mesothelial surface of the nodule (Fig. 6C), except where the no-
dules were pushed into adjacent tissues such as the liver (Fig. 6B).
By eosin counterstaining, intact collagen ﬁbers of the sub-
mesothelial layer and within the unaffected diaphragm me-
senchyme were apparent. This well-formed connective tissue
prevented inﬁltration of the accumulating nodule mesenchyme,
which is often characteristic of malignant neoplasia (Mutsaers,
2002). By immunoﬂuorescence, Collagen1a1 in the basement
membrane was lost from some mesothelial cells at the nodule
periphery (Fig. 6D). The disruption of the mesothelial basement
membrane is only one hallmark of EMT, however, and could
simply be a result of mechanical stress on these ECM components
from rapid tissue growth in the mesenchyme. A further char-
acteristic of epithelial or mesothelial cells undergoing EMT is a
reduction in cell-surface cadherin expression (Zeisberg and Neil-
son, 2009).
In contrast to the “cadherin switching” characteristicallyundergone by epithelial cells actively undergoing EMT, normal
mesothelial cells may express all of the three main cadherins (E-
Cadherin, N-Cadherin, and P-Cadherin), with a preference for
N-Cadherin (Simsir et al., 1999). When these cell-surface proteins
were assayed in β-catenin gain-of-function diaphragm nodules
(Fig. 6J–L), no loss was detected, though differential expression in
the lung (Fig. 6J’–L’) did serve as a positive control. Of the known
acquired mesenchymal markers of EMT, we were limited to pro-
teins speciﬁcally localized in the diaphragm and not widely ex-
pressed (since the mesothelium is derived from mesenchyme).
Twist1 was a prime candidate, though it is also expressed during
normal diaphragm development (most likely initiating mesench-
ymal gene programs), which is a confounding factor for assaying
EMT. By immunoﬂuorescence (Fig. 6E), it was clear that almost the
entire area of mesenchymal overgrowth was Twist1 positive. Ad-
ditionally, a lack of mesenchymal co-labeling with Wt1 was ob-
served, which is unique given that extensive co-labeling is nor-
mally seen in the wildtype diaphragm at this age (Supplementary
Fig. 1C). Other markers of undifferentiated mesenchyme were es-
tablished in the diaphragm, and were also present in and around
the accumulating mesenchymal nodules, such as Sox9 (SRY (sex
determining region Y)-box 9) (Fig. 6F) and Pdgfra (Platelet-derived
growth factor receptor alpha) (Fig. 6G) (Furuyama et al., 2011;
Uezumi et al., 2014). Labeling of several differentiated cell types by
muscle marker Myosin (Fig. 6G) and connective tissue marker
TCF4 (Fig. 6H) indicated that these cells were absent from the bulk
of the nodule mesenchyme. Additionally, unlike the results of the
cell death assay at E12.5 where apoptosis was reduced, at E13.5 we
began to see Cleaved Caspase 3-positive cells in the mesenchyme
of the diaphragm nodules (Fig. 6I). This suggests that the nodules
are not able to sustain themselves due to the speciﬁc time re-
quirement for active β-catenin. Taken together, these data do not
clearly support an induction of EMT in the mesothelium due to β-
catenin overactivation, since the mesothelial structure generally
remains intact and cadherin localization in the diaphragm is un-
changed. We can conclude, however, that constitutive activation of
β-catenin in the mesothelium results in the accumulation of un-
differentiated mesenchyme in localized regions of the diaphragm
by E13.5.
3.7. Wt1 maintains mesothelial integrity while both Wt1 and β-ca-
tenin are required for appropriate differentiation of the diaphragm
mesenchyme
Previous work established that there is a defect in lung me-
sothelial structure of the Wt1 mutant mouse, in addition to com-
monly observed defects in EMT-associated signaling (Cano et al.,
2013; Karki et al., 2014). When the diaphragm mesothelial cell
morphology of the Wt1 null embryos was analyzed by histology
(Fig. 7E–H), the cells appeared morphologically to be more cu-
boidal and lacked ECM components such as elastin ﬁbers, con-
sistent with an immature phenotype. Similarly, a Slit3 deﬁcient
mouse model of CDH also displayed decreased presence of elastin
at E13.5 in the central tendon mesothelium (Yuan et al., 2003).
Following the same analysis, β-catenin loss-of-function diaphragm
mesothelium appeared normal in structure and maturity (Fig. 7M
and N). The non-muscle mesenchyme was assayed for appropriate
differentiation, given the ampliﬁcation of undifferentiated me-
senchyme markers in the β-catenin gain-of-function diaphragms.
Twist1-positive mesenchyme labeled by immunohistochemistry
was signiﬁcantly reduced in the posterior diaphragms of Wt1 null
(Fig. 7C and D) and β-catenin loss-of-function (Fig. 7K and L)
embryos. Other differentiated cell type markers, such as Myosin,
were reduced in Wt1 null posterior diaphragms (Fig. 7A and B) but
not in the β-catenin loss-of-function diaphragms (Fig. 7I and J).
Additionally, Podocalyxin, a cell surface protein present in the
Fig. 7. Wt1 and β-catenin are necessary for proper posterior diaphragm patterning. Differentiation in the posterior diaphragm of Wt1GFPCre null embryos was assayed by
immunostaining at E12.5 for Pdgfra and MF20-positive muscle (A, B), and at E13.5 for Twist1 (C, D). An asterisk labels a region of positive muscle staining (A) and a box
(D) indicates differential Twist1 staining in a region of the posterior diaphragm adjacent to site of defect (evident by lung herniation) (D). Mesothelial cell differentiation was
assayed by histology of elastin ﬁbers at E14.5 (E, F) and H&E staining at E13.5 for analysis of morphology (G, H). Note positively stained elastin ﬁbers are still seen in
mesothelium on abdominal surface (asterisk). Arrows (E, F) indicate presence and absence of elastin in the wildtype and mutant, respectively, and yellow lines (G, H) are
drawn below the mesothelium. Co-immunoﬂuorescence of Myosin (MF20) and Podocalyxin (PCLP1) (I, J) performed on E13.5 Wt1CreERT2;Bcatfx sagittal sections showed no
difference from wildtype. Further immunohistochemistry (K, L) revealed loss of Twist1 in diaphragm mesenchyme (within dotted lines). Analysis of β-catenin loss-of-
function diaphragms at E13.5 by histology for elastin (M, N) also shows no change. Wt1GFPCre mutants at E12.5 demonstrated wildtype levels of mesothelial PCLP1 (O, P)
detected by immunoﬂuorescence in the posterior diaphragm. Single lines label the elastin-stained mesothelium (arrows, M and N) and white arrows indicate PCLP1-positive
mesothelium (O, P). Scale bars: A–D, I–L, O and P, 100 mm; E–H, M and N, 50 mm.
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and P). Therefore, our data suggest that Wt1 functions through β-
catenin signaling to speciﬁcally regulate Twist1, which drives the
appropriate differentiation of the diaphragm mesenchyme. β-ca-
tenin is not required for all aspects of Wt1 signaling, as there are
defects in mesothelial maturation that appear to be unique to the
Wt1 null model. Our ﬁndings identify a more extensive role for
Wt1 function in the developing diaphragm that most likely targets
additional downstream genes other than β-catenin.
4. Discussion
4.1. Conditional perturbation of β-catenin signaling downstream ofWt1 is necessary and sufﬁcient to drive tissue-speciﬁc diaphragm
phenotypes at a precise time in development
Embryonic lethality has prohibited prior investigation of the
mechanisms underlying the formation of Wt1 null diaphragm
defects. One of several possible Wt1 downstream signaling path-
ways, Wnt signaling, has also been unexplored in the diaphragm,
largely due to the need to perform site and time speciﬁc manip-
ulation of the pathway to avoid severe, global developmental de-
fects. We were able to utilize the inducible Wt1CreERT2 mouse tool
along with β-catenin ﬂoxed mice to conditionally target a subset of
diaphragm cells without extensive recombination in other vital
organs such as the heart. β-catenin loss-of-function and gain-of-
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tenin downstream of Wt1. Evidence for this relationship includes
the phenocopy of the β-catenin loss-of-function and the Wt1 null
diaphragm defects (in which mesothelial β-catenin is drastically
reduced), the ability of constitutive activation of β-catenin to res-
cue the Wt1 null diaphragm defect, and the overall retention of
Wt1 expression in the mesothelium of diaphragms with loss of β-
catenin. Though the stabilization of β-catenin resulted in closure of
the diaphragmatic defect, the tissue was not fully restored to a
normal state. This tissue was highly undifferentiated, perhaps due
to an inappropriately high level of Wnt activation or due to other
pathways Wt1 may be targeting. Our ﬁndings reinforce studies
associating Wt1 and β-catenin in cardiac development (Von Gise
et al., 2011) and provide additional evidence for this relationship
with the analysis of experiments conditionally activating β-
catenin.
The timing of signaling events during diaphragm development
has remained elusive without the ability to conditionally target
developing diaphragm cells with an inducible mouse tool. We
chose to test the inducible Wt1CreERT2 mouse line, as it has proven
effective when used for in depth studies of the heart (Zhou et al.,
2008). Our analysis of Wt1 contribution using Wt1CreERT2and
R26Rlacz indicated that this mouse line would provide a speciﬁc,
robust Cre-recombinase tool for probing mechanisms of dia-
phragm development. Based on our ﬁndings from fate mapping
and β-catenin manipulation experiments, E10.5–E11.5 was identi-
ﬁed as a critical time window for essential Wnt signaling during
diaphragm development. As suspected based on the dynamic shift
of Wt1 contribution during early organogenesis, β-catenin ma-
nipulation induced earlier than E10.5 was unable to create a dia-
phragm phenotype. Unfortunately, we cannot deﬁnitively elim-
inate the possibility that β-catenin has a role before this time be-
cause the developmental timing of Wt1 expression driving the
inducible Cre does not appear to promote complete recombination
in the mesothelium earlier than E10.5. The particular timing that
we were able to establish supports a key model for CDH in mice, in
which diaphragm development at the PPF stage (E11.5) is ex-
tremely vulnerable to any defects in basic cellular processes that
may then act as a driving force for the formation of diaphragm
phenotypes (Clugston et al., 2006; Jay et al., 2007; Merrell et al.,
2015; You et al., 2005).
4.2. Mesothelial signaling in the diaphragm may be necessary to
regulate the proper differentiation of the posterior diaphragm
mesenchyme
Previous work carried out on the mesothelium in other organs,
such as the lung, identiﬁed a model in which mesothelial signal-
ing, apart from epithelial–mesenchymal transition (EMT), is ne-
cessary for proper mesenchymal gene expression (Yin et al., 2011).
As early as E11.5, the wildtype diaphragm has a distinctive me-
sothelial layer with cell-type speciﬁc gene expression as well as
unique protein localization at the cell surface and in the basement
membrane, the latter of which cannot be maintained when Wt1 is
lost. These mesothelial characteristics, as well as additional fea-
tures of maturation, persist beyond embryonic development and
continue to be maintained in the adult diaphragm, making it cri-
tical that they are established correctly. Though β-catenin was not
speciﬁcally required for the formation of mature mesothelium, it
was evident that it is responsible for appropriate signal trans-
duction in this tissue. Analysis of Wt1 (or GFP) immunoﬂuorescent
labeling in the genetically manipulated mesothelial cells desig-
nated functions for both β-catenin and Wt1 in the maintenance of
the Wt1-positive cell population. With loss of either gene, a re-
duction in this subset of posterior diaphragmatic mesothelial cells
was observed without a detectable change in total cell number.We hypothesize that mesothelial cells co-expressing Wt1 and β-
catenin have a speciﬁc gene expression proﬁle that provides a
signaling function distinct from the adjacent Wt1-negative me-
sothelium. Perhaps the establishment and maintenance of the
correct proportion of these two cell populations in early dia-
phragm development is necessary for proper morphogenesis.
Additionally, it is unclear whether changes in mesothelial cell
proliferation are partly responsible for the diaphragm phenotypes
observed, although our ﬁndings are similar to those reported in
the PPF of the nitrofen-induced rat model of CDH (Clugston et al.,
2010). Similarity between the deﬁciencies observed in the Wt1-
positive subpopulation of cells in Wt1 null and β-catenin loss-of-
function diaphragmatic mesothelium suggests that cell-autono-
mous signaling of these genes may form a feedback loop that is
necessary to maintain proper expression of other diaphragm me-
sothelial genes that are required for these cells to mature
appropriately.
In addition to the mesothelial defects that result from Wt1 and
β-catenin deletion, we also identiﬁed speciﬁc deﬁciencies in the
diaphragm non-muscle mesenchymal cells triggered by increased
cell death and failure to maintain the Twist1-positive cell popu-
lation. The apparent inability to maintain Twist1 expression is
consistent with work demonstrating that Twist1 expression (as
well as EMT) is defective in Wt1 knockout embryonic stem cells
(Martínez-Estrada et al., 2010). Reduction of Twist1 localization in
mesenchymal cells of the posterior diaphragm is also signiﬁcant
because Twist1 is an established downstream target of Wnt sig-
naling (Reinhold et al., 2006). To gain additional knowledge about
the similarities in the mutant phenotypes, we were able to identify
inappropriately activated mechanisms of diaphragm development
in a β-catenin gain-of-function model, where ampliﬁed cell po-
pulations could be readily identiﬁed. Using this tool, Wt1-derived
Twist-1 positive mesenchymal cells accumulated uncontrollably
when β-catenin activation occurred in the PPF-speciﬁc time win-
dow (E10.5–E11.5). We propose that the posterior diaphragm de-
fects in our loss-of-function models arise primarily due to failed
induction of a mesenchymal differentiation program by Twist1 in
the non-muscle mesenchymal cells. This is suspected based upon
the larger proportion of dysfunctional mesenchymal cells (com-
pared to mesothelium), which may compromise the structural
integrity of the posterior diaphragm. Our data suggest that the
diaphragm mesothelium functions to promote both cell-autono-
mous signaling driving mesothelial gene expression and non-cell-
autonomous signaling that regulates mesenchymal Twist1 ex-
pression, contributing to proper organogenesis. Many phenotypic
characteristics are shared between the two mutant models, but
several differences, mentioned above, could be a result of either
the speciﬁc functions ofWt1 and β-catenin in the diaphragm or the
conditional targeting of β-catenin in this system. Following the
comparison of speciﬁc changes in normal protein localization in
the diaphragms of these genetic mouse models, the phenotypes of
Wt1 and conditional β-cateninmutant mice were assessed, and we
were able to develop a model for the regulation of diaphragm
development by Wt1/β-catenin signaling (Fig. 8).
4.3. Development of a tissue-speciﬁc genetic mouse tool to model the
pathogenesis of human CDH
Germline deletion of CDH candidate genes in mice often results
in embryonic lethality in mid-gestation, limiting the ability to
translate studies to postnatal disease mechanisms of human CDH.
We have developed an inducible conditional mutant model in the
mouse that is able to survive until birth due to time-speciﬁc de-
letion of β-catenin in Wt1-derived cells. The characterization of
diaphragmatic mesothelial cells has been a focus of our studies,
due to the prominent expression of Wt1 in this tissue, however,
Fig. 8. A model for Wt1 and β-catenin regulation of mesothelial maintenance signaling necessary for proper differentiation of the posterior diaphragm mesenchyme. (A) A
summary of the similarities and differences seen in the Wt1 null and Wt1CreERT2;Bcatfx mutant diaphragm phenotypes. (B) A schematic summarizes our ﬁndings comparing
the dynamics of diaphragm differentiation in Wt1 null, β-catenin loss-of-function and gain-of-function embryos and proposes a mechanism that, when defective, results in
the phenotypes observed.
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inducible Cre mouse that speciﬁcally targets the mesothelium of
the diaphragm. It remains unclear which gene promoter would
drive ideal mesothelial-speciﬁc recombination during the critical
PPF-period of diaphragm development (E11.5–E12.5). For example,
Mesothelin would be an excellent candidate to drive mesothelium-
speciﬁc Cre-recombinase, however studies in the liver and lung
have determined that this gene is not expressed until later orga-
nogenesis (Dixit et al., 2013; Onitsuka et al., 2010). Alternatively,
Podocalyxin (PCLP1) expression was detected in early mesothelial
cells coating the liver in these studies, and we conﬁrmed that it
was also present in diaphragm mesothelium as early as E11.5
(unpublished data). Unfortunately, simultaneous expression in
vasculature precludes the use of a PCLP1-Cre mouse for me-
sothelial-speciﬁc studies. This expression pattern is a common
limiting factor indicative of early mesothelial gene functions in
multiple mesenchymal lineages. Nevertheless, the development of
an inducible PCLP1-driven mouse tool could allow for furtherdetailed studies of the immature diaphragm mesothelium.
We have described a valuable genetic system to target the
mouse diaphragm consistently without severely affecting the
heart or otherwise causing intrauterine demise. Knowledge ofWt1
function in the diaphragm has been expanded by our ability to
manipulate the genes Wt1 and β-catenin simultaneously utilizing
tissue-speciﬁc Cre-lox mouse tools. Further studies analyzing the
cardiopulmonary phenotype of β-catenin loss-of-function mice
could pair gene signaling changes in the diaphragm with CDH-
associated defects in these important organ systems, as these tis-
sues may not be directly targeted by the speciﬁc timing and lo-
calization of the Wt1CreERT2 mouse tool. We have established a
possible role for diaphragmatic mesothelial cells in all mouse
models of CDH, given that many key genes in addition to Wt1 and
β-catenin can be detected in this cell layer.
Although deﬁciencies in the mesothelium and the canonical
Wnt signaling pathway generate a CDH phenotype in mice, their
implication in human CDH has not been proven. Essential genes
N.D. Paris et al. / Developmental Biology 407 (2015) 40–56 55involved in the Wnt signaling pathway may play a role in human
CDH pathogenesis, although cytogenetic data and signiﬁcant het-
erogeneity in the population suggest that human genetic ab-
normalities in this pathway may result in more phenotypic var-
iation than in the mouse (Pober, 2008; Wat et al., 2011). Thus, the
mouse may not be an entirely accurate disease model. The re-
lationship between Wnt signaling and human CDH, as well as the
functional role of the human diaphragmatic mesothelium, will
need to be further explored. It is also possible that there are ad-
ditional roles forWt1 in human diaphragm development that have
not yet been identiﬁed through the investigation ofWt1mutations
associated with complex and syndromic CDH (Antonius et al.,
2008; Suri et al., 2007). Ultimately, this work and future studies in
the mouse will advance the understanding of the dynamics of
diaphragm development and the signaling deﬁciencies which may
contribute to the pathogenesis of CDH in humans.Acknowledgments
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